TORNTPHARM / FY26 summary

The year in one view.

Torrent Pharmaceuticals · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

32,027

₹ Cr where applicable

PAT across quarters

5,341

₹ Cr where applicable

Source quarters

11

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
9 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 791 · Positive source sentimentQ1 FY24Q2 FY24: 825 · Positive source sentimentQ2 FY24Q3 FY24: 869 · Positive source sentiment · 2024-01-26Q3 FY24Q4 FY24: 883 · Positive source sentiment · 2024-04-25Q4 FY24Q2 FY25: 939 · Positive source sentimentQ2 FY25Q3 FY25: 914 · Watch source sentimentQ3 FY25Q4 FY25: 964 · Watch source sentimentQ4 FY25Q1 FY26: 1,032 · Positive source sentimentQ1 FY26Q2 FY26: 1,083 · Positive source sentimentQ2 FY261,083791
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.